Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amici Capital is a New York-based investment management firm and hedge fund manager, not an operating life sciences, biotech, pharma, or healthcare company. Available public sources describe it as an investment adviser focused on pooled investment vehicles, equities, and fundamental analysis rather than drug development, medical products, or healthcare services. The firm appears to manage hedge fund capital and has been associated with public-equity investing activity, including historical SEC-reported holdings. Because it is a financial firm rather than a therapeutic developer, fields such as pipeline, modalities, targets, and indications are not applicable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amici Capital.